Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hecla Mining (HL) Stock Price Target Raised at BMO Capital Markets
NEW YORK (TheStreet) -- BMO Capital Markets increased its price target on Hecla Mining Co. (HL - Get Report) to $3 from $2.75 and maintained its "outperform" rating on the stock.
http://www.thestreet.com/story/13471790/1/hecla-mining-hl-stock-price-target-raised-at-bmo-capital-markets.html?puc=yahoo&cm_ven=YAHOO
Hecla Mining (HL) Stock Price Target Raised at BMO Capital Markets
NEW YORK (TheStreet) -- BMO Capital Markets increased its price target on Hecla Mining Co. (HL - Get Report) to $3 from $2.75 and maintained its "outperform" rating on the stock.
http://www.thestreet.com/story/13471790/1/hecla-mining-hl-stock-price-target-raised-at-bmo-capital-markets.html?puc=yahoo&cm_ven=YAHOO
Very nice close, next stop $2.65, great volume
There's the break, just close above the 200 SMA, now
Richmont Mines Inc. (TSE:RIC) had its target price raised by TD Securities from C$6.50 to C$9.00 in a research note issued to investors on Friday, Marketbeat.com reports. The firm currently has a “buy” rating on the stock. TD Securities’ price target would indicate a potential upside of 36.99% from the stock’s current price.
http://www.financial-market-news.com/td-securities-increases-richmont-mines-inc-ric-price-target-to-c9-00/839011/
Richmont Mines Inc. (NYSE MKT: RIC) announced that it will release the Corporations’ fourth quarter and annual financial results for the period ended December 31, 2015 before the market open on Monday, February 22, 2016.
Richmont Mines Inc. (NYSEMKT:RIC) shares increased 2.75% in last trading session and ended the day at $4.49. RIC Gross Margin is 17.90% and its return on assets is 6.40%. Richmont Mines Inc. (NYSEMKT:RIC) quarterly performance is 53.24%.
http://www.stocktranscript.com/stock-runners-asterias-biotherapeutics-inc-nysemktast-richmont-mines-inc-nysemktric-pharmerica-corporation-nysepmc-ply-gem-holdings-inc-nysepgem/76929/
I sure like the sound of this.......
http://sonoranweeklyreview.com/richmont-mines-inc-usas-big-gap-up-today-points-to-less-stock-risks/
Don't hate me but I have been in this one from $1.47, lol. Loving this, knew it was only a matter of time...... Flipped it a few times.......
She's really getting her legs now, buckle up.......
This i really looking nice the last several days. Watching close to see if it can break resistance at 3.68......
I looked at a 3 year chart on this one and it really grabbed my eye. Think I might take an opening position. I like that it's holding above the 50 SMA, and the last 3 days dojis look pretty strong for a move up from here.......
That would be nice since I loaded up cheap this morning. What do you base your projections on? This was originally intended to be a fairly quick daytrade, but if you can convince me what else to be watching for, I might give it a few days more time.........
Holy CRAP up .60 in pre market already........
ZGNX - Analysts at Zacks have given a short term rating of hold on Zogenix Inc (NASDAQ:ZGNX) with a rank of 3. The company has received an average rating of 1.4 from 5 brokerage firms. 4 analysts have rated the company as a strong buy. The company has been rated as hold from 1 Wall Street Analysts.
Company has received coverage from different analysts. Empire Asset Management initiates coverage on Zogenix, Inc. (NASDAQ:ZGNX). Empire Asset Management has a Buy rating on the counter. As per the latest report, the brokerage house announces the price target to $5 per share.
Zogenix, Inc. (NASDAQ:ZGNX) recorded a 10.17% change in the short interest in the past month. The 3-month %change in short interest stands at 11.95%. The monthly shorted shares now measure at 0.1838 times the total shares outstanding. The companys short ratio is at 5.13. The average volume for the past 20 trading days is 5,223,443 shares. Volume for the last 20 trading sessions stands at 3.41% of the outstanding shares.
Analysts at Zacks have given a short term rating of hold on Zogenix Inc (NASDAQ:ZGNX) with a rank of 3. The company has received an average rating of 1.4 from 5 brokerage firms. 4 analysts have rated the company as a strong buy. The company has been rated as hold from 1 Wall Street Analysts.
Company has received coverage from different analysts. Empire Asset Management initiates coverage on Zogenix, Inc. (NASDAQ:ZGNX). Empire Asset Management has a Buy rating on the counter. As per the latest report, the brokerage house announces the price target to $5 per share.
Zogenix, Inc. (NASDAQ:ZGNX) recorded a 10.17% change in the short interest in the past month. The 3-month %change in short interest stands at 11.95%. The monthly shorted shares now measure at 0.1838 times the total shares outstanding. The companys short ratio is at 5.13. The average volume for the past 20 trading days is 5,223,443 shares. Volume for the last 20 trading sessions stands at 3.41% of the outstanding shares.
Really need a close above $2.70. This video from 3/30 is still valid today
[url][/url][tag]http://claytrader.com/stock_chart/PLUG/[/tag]
Sometimes I find myself looking for the 'LIKE' button, a la Facebook.........
$6.50 would be fine with me.......
In a research note published on Tuesday, FBR Capital decreased the target price on Plug Power Inc (NASDAQ:PLUG) stock from $8 to $6.5, while retaining a Buy rating. The reduction in target price is largely driven by the higher operating expenses expected in fiscal year 2015 (FY15).
[url][/url][tag]http://www.bidnessetc.com/37813-plug-power-inc-plug-target-price-trimmed-to-65-at-fbr-capital/[/tag]
A close above the 200 SMA would be nice here..........
I read some of these posts and wish the posts had a LIKE button like Facebook, lol
Shares of Plug Power (PLUG - Get Report) were gaining 3.8% to $2.69 Thursday after the fuel cell manufacturer announced a new order from FreezPak Logistics.
Plug Power announced that FreezPak Logistics selected its full-service GenKey solution for a new cold storage distribution center freezer warehouse that it currently under construction in New Jersey.
The GenKey deployment for the freezer warehouse includes 25 GenDrive fuel cells, a GenFuel outdoor hydrogran storage infrastructure with two indoor dispensers, and GenCare service for the fuel cells and hydrogen system. The contract with FreezPak Logistics also includes a 10-year hydrogen supply agreement.
"Plug Power worked together as partners alongside FreezPak to develop and install a mini-GenFuel system, making the very real operational and productivity benefits of hydrogen fuel cells a reality for smaller fleet customers, like FreezPak," Plug Power CEO Andy Marsh said in a statement.
[url][/url][tag]http://www.thestreet.com/story/13084799/1/one-factor-driving-plug-power-plug-stock-up-today.html?puc=yahoo&cm_ven=YAHOO[/tag]
[url][/url][tag]http://seekingalpha.com/article/3007296-market-oversells-zogenix-after-company-exits-pain-business[/tag]
Market Oversells Zogenix After Company Exits Pain Business
Mar. 17, 2015 12:30 PM ET | 2 comments | About: Zogenix, Inc.
Summary
Shares tanked 27% after Q4 report and Zohydro sale/personnel transfer, to bring the market cap to below $200M.
However, after the transaction, Zogenix is now flush with >$100M cash and is stable til the end of 2016. And with Zogenix, another M&A is never out of the picture.
The remaining pipeline consist of two advanced-stage potential blockbusters, which are definitely worth more than the balance of the market cap.
Zogenix (NASDAQ:ZGNX) is a small specialty pharmaceutical company developing therapies that address central nervous system (NYSE:CNS) conditions. It has a market cap of $199.37 million and on March 10, reported financial results for the fourth quarter ended December 31, 2014. On the same day, Zogenix announced the sale of its Zohydro ER (extended-release hydrocodone) business, including the transfer of the Zogenix pain sales team, to Pernix Therapeutics (NASDAQ:PTX) for $100 million plus milestones up to $283.5 million. The transaction transformed Zogenix to a cash-laden company with a late-stage CNS pipeline. Zogenix can also decide to go shopping, like it did when it acquired Brabant Pharma in October to obtain their Brabafen (now ZX008).
Remaining lead candidates compare favorably to other big sellers.
ZX008 (low-dose fenfluramine) and Relday (once-monthly subcutaneous risperidone) are Phase 3-ready product candidates. Fenfluramine (Pondimin) was half of the notorious "fen-phen," a widely used off-label combination with phentermine for long-term management of obesity in the 1990s. Pondimin and the related drug Redux (dexfenfluramine) were both withdrawn from the market in 1997 after causing heart valve disease in an unacceptably high number of patients. Over 30% of patients developed valvulopathy on a daily Pondimin dose of at least 20 mg/day. Pondimin had been on the market for more than 20 years before the problem became widely known.
ZX008 has orphan drug designation in the U.S. and Europe for the treatment of Dravet syndrome. It is estimated that 1 in 20,000-40,000 children have this genetic disorder of the brain. The potential to reduce the frequency of serious seizures (childhood mortality >15%) and the accompanying complications (infections, developmental disability) may heavily outweigh the cardiac risks of fenfluramine use.
Small fenfluramine dosages in the range of 0.12-0.90 mg/kg/day were effective in children 1-16 years of age. Anecdotally, researches told of kids who developed the feared heart valve thickening, but whose parents refused to stop treatment. Seventy percent of the children remained seizure-free for more than a year. If even half of this efficacy is confirmed by the Phase 3, it would still be superior to any treatment regimen reported in literature. While it is premature to speculate on pricing, the orphan drug status suggests that ZX008 is a future blockbuster when compared to, say, products from BioMarin (NASDAQ:BMRN) that are netting $200-300 million annually from much rarer diseases. Zogenix's remaining personnel should easily be able to cover the few Dravet syndrome experts per territory.
Yea, sure needs to break back above the 200 and hold.
Gold and Silver both have been fairly hammered lately, a move back up and this flies.........
OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI): 4 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $7.38 in OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI). However, the stock price could fluctuate by $ 4.61 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $14 price target with the lower price estimate is calculated at $4
The short interest information of the company was disclosed in the recent information. OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI), In a major positive the short interest in OncoGenex Pharmaceuticals Inc. – Common Shares plummeted by 20.7% or 89,935 shares. The final shorts are 1.7% of the total floated shares. The positions dropped from 434,273 shares on January 30,2015 to 344,338 on February 13,2015. Inculcating the per-day average trading of 180,040 shares, the days to cover are 2.
Shares of OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) rose by 1.1% in the past week and 14.18% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 1.38% and the outperformance increases to 8.24% for the last 4 weeks.
OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) made into the market gainers list with the shares advancing 7.88% or 0.19 points. Due to strong positive momentum, the stock ended at $2.6, which is also near the days high of $2.72. The stock began the session at $2.42 and the volume stood at 1,392,016 shares. The previous session had ended at $2.41. The 52-week high of the shares is $14.25 and the yearly low is $1.92. The company is a major component of the market with a cap of $55 million and is a highly liquid scrip with 21,281,000 shares in outstanding.
OGXI, keep an eye on it
(NASDAQ:OGXI): 4 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $7.38 in OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI). However, the stock price could fluctuate by $ 4.61 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $14 price target with the lower price estimate is calculated at $4
The short interest information of the company was disclosed in the recent information. OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI), In a major positive the short interest in OncoGenex Pharmaceuticals Inc. – Common Shares plummeted by 20.7% or 89,935 shares. The final shorts are 1.7% of the total floated shares. The positions dropped from 434,273 shares on January 30,2015 to 344,338 on February 13,2015. Inculcating the per-day average trading of 180,040 shares, the days to cover are 2.
Shares of OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) rose by 1.1% in the past week and 14.18% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 1.38% and the outperformance increases to 8.24% for the last 4 weeks.
OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) made into the market gainers list with the shares advancing 7.88% or 0.19 points. Due to strong positive momentum, the stock ended at $2.6, which is also near the days high of $2.72. The stock began the session at $2.42 and the volume stood at 1,392,016 shares. The previous session had ended at $2.41. The 52-week high of the shares is $14.25 and the yearly low is $1.92. The company is a major component of the market with a cap of $55 million and is a highly liquid scrip
[url][/url][tag]http://stockcharts.com/h-sc/ui[/tag]
Off to the races.......
It ran because the surprise move by the SNB caused gold to spike HARD overnight......
I have $1.47 entry, took partial profits @ %3.51 earlier and am riding free money from here on out.......
Run baby, run.If we can break that $3.65 level and hold, it's off to the races
Nice.......
Not sure what is driving this thing but I LIKE it a lot........
I got it at $1.47 so looking at a double bagger to take profit on some and se what the rest does..... Just play the chart and take what it gives
Ric breaking out
I am thinking short squeeze soon, this just gets better and better
http://www.watchlistnews.com/richmont-mines-short-interest-up-31-2-in-october-ric/159575/
I am thinking short squeeze soon, this just gets better and better
http://www.watchlistnews.com/richmont-mines-short-interest-up-31-2-in-october-ric/159575/